ClinicalTrials.Veeva

Menu

Study About Drug Resistance of Mycobacterium Tuberculosis

S

Sohag University

Status

Not yet enrolling

Conditions

Pulmonary and Extra- Pulmonary Tuberculosis (TB)

Study type

Observational

Funder types

Other

Identifiers

NCT07169149
Soh-Med-25-8---3MD

Details and patient eligibility

About

Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Early, rapid and accurate diagnosis of all TB patients and prompt treatment with any form of drug-susceptible or drug resistant TB is fundamental. Identifying the pattern of drug resistance will ensure that the most effective therapy can be selected. The aim of this study is to assess the prevalence and patterns of drug resistance of mycobacterium tuberculosis and to detect the possible risk factors associated with resistant cases.

Enrollment

250 estimated patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • geneXpert positive patients in pulmonary and extrapulmonary cases

Exclusion criteria

  • age below 12 years

Trial contacts and locations

1

Loading...

Central trial contact

Omnia Abdelazeem Zahran

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems